Light Mode
$15.65 ↑ +0.00 (+0.00%) Trading Up from the previous close of $15.65, $0.50 below the day’s high of $16.15
-2.20 (-12.32%) / 6M
Momentum, market sentiment, and recent alerts
STVN reads neutral: price sits below both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is -30.1%.
No alerts for STVN in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.